Highlights
A collection of news and information related to Bristol Myers Squibb Company published by this site and its partners.
Displaying items 1-12 of 53
» View chicagobreakingbusiness.com items only
1
2
3
4
5
•
Next >
-
UK scientists win funding for new kind of anticoagulant drug
ReutersLONDON, June 17 (Reuters) - British scientists have won early financial backing for a new kind of anticoagulant drug they believe may prevent dangerous blood clots without causing bleeding - a previously unachievable goal. Index Ventures, working with...Tags: Pradaxa (drug), Science and Technology, Johnson & Johnson Inc., Heart Attack, University of Cambridge
-
Drugmakers to cooperate in safety review of diabetes drugs
ReutersNEW YORK (Reuters) - Global drugmakers said on Wednesday they would cooperate with an independent review to address concerns of a potential link between widely used diabetes medicines and pancreatic cancer and other safety problems. The American Diabetes...Tags: Chemical Industry, American Diabetes Association, Food and Drug Administration, Medical Research, AstraZeneca Plc
-
UPDATE 1-Former Bristol-Myers executive admits to insider trading
Reuters* Robert Ramnarine pleads guilty to securities fraud * Defendant accused of buying options in takeover targets By Jonathan Stempel June 10 (Reuters) - A former Bristol-Myers Squibb Co finance executive on Monday pleaded guilty to an insider trading...Tags: Judges, Insider Trading, Lawyers, ZymoGenetics Incorporated, Gilead Sciences Inc.
-
U.S. RESEARCH ROUNDUP: Visa, Moody's, Facebook, BNY Mellon
ReutersJune 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies including 3M and Facebook on Monday. HIGHLIGHTS * BNY Mellon : Raymond James raises price target to $33 from $31 * Western Union Co :...Tags: Media Industry, Personal Data Collection, Stericycle Incorporated, Sempra Energy, Liquidity Services Incorporated
-
AstraZeneca to pay up to $1.15 billion for Pearl Therapeutics
The Philadelphia InquirerDrugmaker AstraZeneca PLC said Monday that it had agreed to pay up to $1.15 billion for Pearl Therapeutics Inc., a privately held company based in Redwood City, Calif. Pearl's research focus is inhaled medication for respiratory diseases, specifically...Tags: Chemical Industry, The Philadelphia Inquirer, Diseases and Illnesses, COPD, Food and Drug Administration
-
FDA grants priority review status to Gilead's hepatitis C drug
ReutersJune 7 (Reuters) - Biotechnology company Gilead Sciences Inc said the U.S. Food and Drug Administration (FDA) granted priority review to its experimental hepatitis C drug sofosbuvir. The FDA grants priority reviews to medicines that are considered...Tags: Hepatitis C , Science and Technology, Chemical Industry, Biotechnology, Food and Drug Administration
-
U.S. RESEARCH ROUNDUP: Abbott, Ciena, Visa, Bristol, Intel
ReutersJune 7 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including J&J, Microsoft and Intel, on Friday. HIGHLIGHTS * U.S. healthcare: Jefferies cuts targets on Bristol-Myers Squibb, others...Tags: Applied Micro Circuits Corporation, Greif Incorporated, Personal Data Collection, James River Coal Co., Arch Coal Incorporated
-
Sanofi avanza en el mercado de la diabetes ante dura competencia
ReutersPor Elena Berton FRANCFORT, 7 jun (Reuters) - En una barrio residencial de Fráncfort, Alemania, una planta de última generación produce diariamente hasta 1 millón de bolígrafos de insulina en el marco de una iniciativa de la farmacéutica francesa...Tags: Lantus (drug), AstraZeneca Plc, Diabetes, Lilly Eli & Co
-
U.S. RESEARCH ROUNDUP: Intel, Google, Bristol, Halliburton, Akamai
ReutersJune 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including CME and TripAdvisor, on Monday. HIGHLIGHTS * Google Inc : Cantor Fitzgerald raises price target to $1030 from $900 *...Tags: Applied Micro Circuits Corporation, Real Estate, State Street Corporation, Littelfuse Incorporated, Golar LNG Limited
-
Merck KGaA's Erbitux beats Avastin in bowel cancer trial
ReutersFRANKFURT, June 1 (Reuters) - Merck KGaA's cancer drug Erbitux was shown to be more effective at prolonging the lives of bowel cancer patients than Roche's Avastin, Merck said. In a drug trial, the two drugs were each given in combination with Folfiri...Tags: Medical Research, Lilly Eli & Co, Colon Cancer, Germany, Bevacizumab (drug)
-
UK cost agency backs Astra, Bristol diabetes drug in some cases
ReutersLONDON, May 30 (Reuters) - Britain's healthcare cost watchdog NICE is recommending a new diabetes drug from Bristol-Myers Squibb and AstraZeneca in some circumstances, marking a change of tack following an earlier blanket rejection. The National...Tags: United Kingdom, Chemical Industry, Metformin (drug), AstraZeneca Plc, Drugs and Medicines
-
Sanofi steps up diabetes drive as rivals raise the stakes
Reuters* French drugmaker banking on improved version of Lantus * Investing in smart technology to bolster diabetes business * Novo Nordisk setback an opportunity in competitive market * Key data on new Sanofi products at ADA meeting this month By Elena...Tags: Deutsche Bank AG, Insulin Injections, Corporate Performance, Research and Development, French Literature
Jun 16, 2013
|Story| Reuters
Jun 12, 2013
|Story| Reuters
Jun 10, 2013
|Story| Reuters
Jun 10, 2013
|Story| Reuters
Jun 10, 2013
|Story| McClatchy-Tribune
Jun 7, 2013
|Story| Reuters
Jun 7, 2013
|Story| Reuters
Jun 7, 2013
|Story| Reuters
Jun 3, 2013
|Story| Reuters
Jun 1, 2013
|Story| Reuters
May 29, 2013
|Story| Reuters
Jun 7, 2013
|Story| Reuters
Original site for Bristol Myers Squibb Company topic gallery.
